Back to mobile site

Benchmark Reiterates Buy Rating on Ultralife (ULBI)

May 28, 2025 7:31 AM EDT Send to a Friend
Benchmark analyst Josh Sullivan reiterated a Buy rating and $14.00 price target on Ultralife (NASDAQ: ULBI).The analyst commented, “We’ve updated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login